Brand Comparisons, Profitability Insights & Top Tips from Dispex
Are you staying ahead of the changes?
At Dispex, we continually monitor changes within the dispensing world, updating our
brand comparison pages as and when changes occur. Our goal is to keep your dispensary
well-informed, efficient, and patient-focused. On our brand comparison pages we also include
“Dispex Top Tips” such as, Prescribe Capsules Generically and dispense Colekal-D3.
What’s Included in Our Brand Comparison Tools?
We provide regularly updated comparisons across a wide range of therapeutic areas:
- Diabetes: Gliptins, Gliflozins, GLP1 agonists
- Women’s Health: Estradiol, Desogestrel, Levonorgestrel IUCDs
- Cardiovascular: NOACs, Diltiazem
- Respiratory: LAMA, LABA, ICS and combination inhalers
Monthly Updates You Can Rely On
Each month, we publish comprehensive updates on:
- Generics costing more than the Drug Tariff
- Concession changes
- Emerging patterns that may affect prescribing decisions
These easy-to-navigate tools do the legwork for your dispensary team-tracking concessions,
comparing generic and branded pricing, and highlighting relevant changes.
While we don’t make direct purchasing recommendations, we do provide clear, data-driven
profitability insights-always underpinned by the understanding that patient care comes first,
and that final prescribing decisions lie with the clinician.
Are You Making the Most of Your Membership?
If you’re a current Dispex member but haven’t yet explored our Profitability Pages, we encourage
you to contact our office for access details, enquiries@dispex.net
Thinking about joining us?
Click here to explore Dispex membership benefits
